Title: A phase 2, randomized, biomarker-driven, clinical study in patients with relapsed or refractory AML with an exploratory arm in patients with newly diagnosed high-risk AML and exploratory arms with varying levels of MCL-1 dependence
Funder
Cardiff & Vale University Health Board
Principal Investigator
Co-Investigators
Alvares, Caroline
Project Details
Net value award figure for Cardiff University: £3,367.00
Start date: 13/06/2019
End date: 30/06/2023
